JOSE MANUEL
VALDIVIELSO REVILLA
CON
Aristotle University of Thessaloniki
Salónica, GreciaPublicacions en col·laboració amb investigadors/es de Aristotle University of Thessaloniki (9)
2024
-
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189
2023
-
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25
-
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455
2021
-
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (Drugs, (2021), 81, 13, (1467-1489), 10.1007/s40265-021-01555-5)
Drugs
-
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
Drugs, Vol. 81, Núm. 13, pp. 1467-1489
-
Intravenous iron therapy and the cardiovascular system: risks and benefits
Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1067-1076
2019
-
Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)
Nature Reviews Nephrology
-
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Nephrology Dialysis Transplantation, Vol. 34, Núm. 2, pp. 208-230
2018
-
Lipid management in patients with chronic kidney disease
Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749